Fig. 3From: Galectin-1 is a poor prognostic factor in patients with glioblastoma multiforme after radiotherapyCancer-specific survival (CSS) estimated according to the expression level of galectin-1. The expression level of galectin-1 was a significant factor of CSS (p = 0.020)Back to article page